LABA/LAMA
Medical abbreviation · Drug Class
| Stands for | Long-acting beta-agonist and long-acting muscarinic antagonist combination |
|---|---|
| Categories | Medical |
LABA/LAMA stands for Long-acting beta-agonist and long-acting muscarinic antagonist combination, a drug class abbreviation.
Dual long-acting bronchodilator inhalers for COPD, such as umeclidinium/vilanterol (Anoro), tiotropium/olodaterol (Stiolto) and glycopyrrolate/formoterol (Bevespi). Combining two bronchodilator mechanisms improves breathing more than either alone.
Example: COPD GOLD group E: LABA/LAMA, add ICS if eosinophils at least 300.
Usage notes
GOLD reports recommend LABA/LAMA as initial maintenance for many symptomatic COPD patients. Adding an inhaled steroid creates "triple therapy" (Trelegy, Breztri), used when exacerbations continue and blood eosinophils are high. These combinations are not used without an ICS in asthma.
Related abbreviations
More drug class abbreviations
- ICS/LABA – Inhaled corticosteroid and long-acting beta-agonist combination
- IMiD – Immunomodulatory imide drug
- INCS – Intranasal corticosteroids
- INSTI – Integrase strand transfer inhibitor
- JAKi – Janus kinase inhibitor
- LABA – Long-acting beta2-agonist
- LAI – Long-acting injectable
- LAMA – Long-acting muscarinic antagonist
- LMWH – Low-molecular-weight heparin
- LTRA – Leukotriene receptor antagonist
- mAb – Monoclonal antibody
- MAOI – Monoamine oxidase inhibitor
See all 113 drug class abbreviations →
This entry is for general education and is not medical advice. Abbreviation use varies between institutions; always confirm in context.